Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Lidocaine Patch 1.8% vs Lidoderm in Healthy Subjects
NCT04149938Phase 1Completed
- Sponsor
- Scilex Holding
- Start
- Sep 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of lidocaine topical system in postherpetic neuralgia (PHN) (2 arms), sponsored by Scilex Holding. Primary endpoints: Peak Plasma Concentration, Area Under the Plasma-Concentration Time Curve from Time 0 to Time 48 hours and 2 more. Started Sep 2016; status: completed.
02
Drugs
lidocaine topical system
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT04149938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149938.